ExeVir Bio
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $39M
Investors
- 9
About ExeVir Bio
Based in Belgium, and founded in 2020, ExeVir Bio BV operates as a biotech firm that develops nanobody therapies for various infectious diseases. The company is a spin-out of VIB and was founded by Xavier Saelens and Nico Callewaert. As of 2023, the company’s CEO is Torsten Mummenbrauer. The company develops viral infection medicines using clinically validated VHH technology. VHH72-Fc, the lead asset, binds to a unique epitope conserved in SARS-CoV-1 and SARS-CoV-2 viruses and stops them from entering the cell. This method could be used both therapeutically and prophylactically. Slowing viral multiplication in the lungs, reducing inflammation, and giving patients critical time to establish their own productive immune response could all be aided by therapeutic use. Prophylactic use could help ringfence an outbreak, safeguard healthcare personnel, and help patients who are at higher risk of severe COVID-19 sickness.
Who invested in ExeVir Bio
9 investors across 2 rounds
See all investors in ExeVir Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ExeVir Bio
Who invested in ExeVir Bio?
ExeVir Bio has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ExeVir Bio raised?
ExeVir Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ExeVir Bio last raise money?
ExeVir Bio's most recent round on record is a Series A, in Mar 2021.
What does ExeVir Bio do?
Based in Belgium, and founded in 2020, ExeVir Bio BV operates as a biotech firm that develops nanobody therapies for various infectious diseases.
Where is ExeVir Bio headquartered?
ExeVir Bio is headquartered in Ghent, Belgium.
Which VCs invest in companies like ExeVir Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at ExeVir Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ExeVir Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.